Immunoglobulins as Radiopharmaceutical Vectors View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2019-04-03

AUTHORS

Danielle J. Vugts , Guus A. M. S. van Dongen

ABSTRACT

With the introduction of the magic bullet concept by Ehrlich and the subsequent development of hybridoma technology by Kohler and Milstein, the world of target-specific protein-based drugs was opened. Since then, numerous immunoglobulins and a few dozen radioimmunoconjugates have been approved by the US Food and Drug Administration (US FDA) and the European Medicines Agency (EMA). In this chapter, we will discuss the array of natural and engineered immunoglobulins that are available as vectors for imaging and therapy as well as their in vivo modes of action. Several critical aspects of the accessibility and expression of targets related to the use of radioimmunoconjugates for imaging and therapy will be also discussed. These two introductory sections are followed by the core of the chapter in which we address the selection of appropriate radionuclide-immunoglobulin combinations, the possible applications of immunoPET and immunoSPECT, and how radiolabeled immunoglobulins can be evaluated. More... »

PAGES

163-179

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-319-98947-1_9

DOI

http://dx.doi.org/10.1007/978-3-319-98947-1_9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1113233441


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vugts", 
        "givenName": "Danielle J.", 
        "id": "sg:person.0665425270.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665425270.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "van Dongen", 
        "givenName": "Guus A. M. S.", 
        "id": "sg:person.0732223564.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732223564.35"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2019-04-03", 
    "datePublishedReg": "2019-04-03", 
    "description": "With the introduction of the magic bullet concept by Ehrlich and the subsequent development of hybridoma technology by Kohler and Milstein, the world of target-specific protein-based drugs was opened. Since then, numerous immunoglobulins and a few dozen radioimmunoconjugates have been approved by the US Food and Drug Administration (US FDA) and the European Medicines Agency (EMA). In this chapter, we will discuss the array of natural and engineered immunoglobulins that are available as vectors for imaging and therapy as well as their in vivo modes of action. Several critical aspects of the accessibility and expression of targets related to the use of radioimmunoconjugates for imaging and therapy will be also discussed. These two introductory sections are followed by the core of the chapter in which we address the selection of appropriate radionuclide-immunoglobulin combinations, the possible applications of immunoPET and immunoSPECT, and how radiolabeled immunoglobulins can be evaluated.", 
    "editor": [
      {
        "familyName": "Lewis", 
        "givenName": "Jason S.", 
        "type": "Person"
      }, 
      {
        "familyName": "Windhorst", 
        "givenName": "Albert D.", 
        "type": "Person"
      }, 
      {
        "familyName": "Zeglis", 
        "givenName": "Brian M.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-319-98947-1_9", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-319-98946-4", 
        "978-3-319-98947-1"
      ], 
      "name": "Radiopharmaceutical Chemistry", 
      "type": "Book"
    }, 
    "keywords": [
      "European Medicines Agency", 
      "use of radioimmunoconjugates", 
      "US Food", 
      "Drug Administration", 
      "Medicines Agency", 
      "magic bullet concept", 
      "expression of targets", 
      "immunoglobulin", 
      "vivo mode", 
      "therapy", 
      "subsequent development", 
      "radioimmunoconjugates", 
      "hybridoma technology", 
      "protein-based drugs", 
      "imaging", 
      "Radiopharmaceutical Vectors", 
      "immunoPET", 
      "administration", 
      "drugs", 
      "Ehrlich", 
      "expression", 
      "food", 
      "target", 
      "Milstein", 
      "action", 
      "possible applications", 
      "use", 
      "combination", 
      "critical aspects", 
      "development", 
      "sections", 
      "aspects", 
      "vector", 
      "accessibility", 
      "chapter", 
      "introduction", 
      "introductory section", 
      "core", 
      "selection", 
      "applications", 
      "Kohler", 
      "agencies", 
      "mode", 
      "world", 
      "array", 
      "technology", 
      "concept"
    ], 
    "name": "Immunoglobulins as Radiopharmaceutical Vectors", 
    "pagination": "163-179", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1113233441"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-319-98947-1_9"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-319-98947-1_9", 
      "https://app.dimensions.ai/details/publication/pub.1113233441"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-05-20T07:43", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/chapter/chapter_223.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-319-98947-1_9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-98947-1_9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-98947-1_9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-98947-1_9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-98947-1_9'


 

This table displays all metadata directly associated to this object as RDF triples.

124 TRIPLES      23 PREDICATES      71 URIs      64 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-319-98947-1_9 schema:about anzsrc-for:11
2 anzsrc-for:1115
3 schema:author Nfbd0b813d3174aeb9c025b75129768e1
4 schema:datePublished 2019-04-03
5 schema:datePublishedReg 2019-04-03
6 schema:description With the introduction of the magic bullet concept by Ehrlich and the subsequent development of hybridoma technology by Kohler and Milstein, the world of target-specific protein-based drugs was opened. Since then, numerous immunoglobulins and a few dozen radioimmunoconjugates have been approved by the US Food and Drug Administration (US FDA) and the European Medicines Agency (EMA). In this chapter, we will discuss the array of natural and engineered immunoglobulins that are available as vectors for imaging and therapy as well as their in vivo modes of action. Several critical aspects of the accessibility and expression of targets related to the use of radioimmunoconjugates for imaging and therapy will be also discussed. These two introductory sections are followed by the core of the chapter in which we address the selection of appropriate radionuclide-immunoglobulin combinations, the possible applications of immunoPET and immunoSPECT, and how radiolabeled immunoglobulins can be evaluated.
7 schema:editor Nb956125d8e104f7b913ac2a6c4c7bc53
8 schema:genre chapter
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf N6f38c7fc7bbb4842bebb106c22b88b35
12 schema:keywords Drug Administration
13 Ehrlich
14 European Medicines Agency
15 Kohler
16 Medicines Agency
17 Milstein
18 Radiopharmaceutical Vectors
19 US Food
20 accessibility
21 action
22 administration
23 agencies
24 applications
25 array
26 aspects
27 chapter
28 combination
29 concept
30 core
31 critical aspects
32 development
33 drugs
34 expression
35 expression of targets
36 food
37 hybridoma technology
38 imaging
39 immunoPET
40 immunoglobulin
41 introduction
42 introductory section
43 magic bullet concept
44 mode
45 possible applications
46 protein-based drugs
47 radioimmunoconjugates
48 sections
49 selection
50 subsequent development
51 target
52 technology
53 therapy
54 use
55 use of radioimmunoconjugates
56 vector
57 vivo mode
58 world
59 schema:name Immunoglobulins as Radiopharmaceutical Vectors
60 schema:pagination 163-179
61 schema:productId Na3f2f2d57d2a42df847b81ba6262c4cd
62 Na63ad3e2fbef4c40a61930657065d09f
63 schema:publisher N0013976e6caa4b12a53619322139c1e1
64 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113233441
65 https://doi.org/10.1007/978-3-319-98947-1_9
66 schema:sdDatePublished 2022-05-20T07:43
67 schema:sdLicense https://scigraph.springernature.com/explorer/license/
68 schema:sdPublisher N8088e91898ff444eb6ad6f71a1a6c06a
69 schema:url https://doi.org/10.1007/978-3-319-98947-1_9
70 sgo:license sg:explorer/license/
71 sgo:sdDataset chapters
72 rdf:type schema:Chapter
73 N0013976e6caa4b12a53619322139c1e1 schema:name Springer Nature
74 rdf:type schema:Organisation
75 N2ddc1ee63d344c558d3008912ef9b3d4 schema:familyName Zeglis
76 schema:givenName Brian M.
77 rdf:type schema:Person
78 N3af9a92ac9364f9ca979dd83f09adb68 schema:familyName Lewis
79 schema:givenName Jason S.
80 rdf:type schema:Person
81 N6f38c7fc7bbb4842bebb106c22b88b35 schema:isbn 978-3-319-98946-4
82 978-3-319-98947-1
83 schema:name Radiopharmaceutical Chemistry
84 rdf:type schema:Book
85 N6f758ae461b74f789b7d8bdb4b9ad4f2 rdf:first sg:person.0732223564.35
86 rdf:rest rdf:nil
87 N806d22b6798342b88a2a2119cb1a32a9 rdf:first N2ddc1ee63d344c558d3008912ef9b3d4
88 rdf:rest rdf:nil
89 N8088e91898ff444eb6ad6f71a1a6c06a schema:name Springer Nature - SN SciGraph project
90 rdf:type schema:Organization
91 Na3f2f2d57d2a42df847b81ba6262c4cd schema:name dimensions_id
92 schema:value pub.1113233441
93 rdf:type schema:PropertyValue
94 Na5b8892823f74a30a56f3e81f143511c schema:familyName Windhorst
95 schema:givenName Albert D.
96 rdf:type schema:Person
97 Na63ad3e2fbef4c40a61930657065d09f schema:name doi
98 schema:value 10.1007/978-3-319-98947-1_9
99 rdf:type schema:PropertyValue
100 Nb312d9b1346648cdbaac6a8aadac908b rdf:first Na5b8892823f74a30a56f3e81f143511c
101 rdf:rest N806d22b6798342b88a2a2119cb1a32a9
102 Nb956125d8e104f7b913ac2a6c4c7bc53 rdf:first N3af9a92ac9364f9ca979dd83f09adb68
103 rdf:rest Nb312d9b1346648cdbaac6a8aadac908b
104 Nfbd0b813d3174aeb9c025b75129768e1 rdf:first sg:person.0665425270.49
105 rdf:rest N6f758ae461b74f789b7d8bdb4b9ad4f2
106 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
107 schema:name Medical and Health Sciences
108 rdf:type schema:DefinedTerm
109 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
110 schema:name Pharmacology and Pharmaceutical Sciences
111 rdf:type schema:DefinedTerm
112 sg:person.0665425270.49 schema:affiliation grid-institutes:grid.16872.3a
113 schema:familyName Vugts
114 schema:givenName Danielle J.
115 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665425270.49
116 rdf:type schema:Person
117 sg:person.0732223564.35 schema:affiliation grid-institutes:grid.16872.3a
118 schema:familyName van Dongen
119 schema:givenName Guus A. M. S.
120 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732223564.35
121 rdf:type schema:Person
122 grid-institutes:grid.16872.3a schema:alternateName Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
123 schema:name Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
124 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...